Digital Pathology Annotation
High-resolution annotations for whole slide images capturing cellular-level structures. We provide the vital ground truth for cancer diagnostics and predictive drug development.
Core Capabilities
Advanced technology built for enterprise scale.
Experts-in-the-Loop
Qualified pathologists and molecular biologists train and lead annotators on complex histopathological datasets and biopsy reports.
Multi-Resolution Expertise
Delivering annotations for Whole Slide Images (WSIs) that capture precise cellular structures for infectious disease detection.
Advanced Semantic Segmentation
Labeling structures like nuclei, cytoplasm, and stroma alongside polygon annotation for marking tumor boundaries.
Pathology-Driven Generative AI
Curating datasets that simulate cellular structures for research, supporting synthetic data generation.
Custom Ontology Development
Developing pathology-specific annotation frameworks tailored to AI model requirements for deeper tissue morphology insights.
Multi-Modality Data Integration
Combining histopathological images with genomic or transcriptomic data for a holistic understanding of disease mechanisms.
Proven Applications
See how industry leaders are leveraging our solutions in production environments.
Discuss Your Use Case
Tumor Segmentation
Enabling precise segmentation of tumors for automated assessment of their characteristics and aggressive behavior.
Leukemia Analysis
Classification and segmentation of cancer cells in bone marrow aspirate images, rigorously reviewed by pathologists.
Breast Cancer Diagnosis
Consensus-based identification of tumor boundaries within histological samples for unbiased IHC analysis models.
Prognostic Predictions
Guiding personalized treatment strategies by combining image patterns with genomic data to predict disease progression.
Telepathology Operations
Structuring annotated images so they can be seamlessly shared among specialists for remote consultations.
Clinical Workflow Optimization
Helping AI assist pathologists with automating biopsy analysis, flagging critical cases, and streamlining reporting.